BCAP31
(B-Cell Receptor-Associated Protein 31 (BCAP31))
Protein Region
Middle Region
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-BCAP31 antibody (Catalog #: ARP46645_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
BCAP31
(B-Cell Receptor-Associated Protein 31 (BCAP31))
Hintergrund
BCAP31 is a member of the B-cell receptor associated protein 31 superfamily. It is a multi-pass transmembrane protein of the endoplasmic reticulum that is involved in the anterograde transport of membrane proteins from the endoplasmic reticulum to the Golgi and in the caspase 8-mediated apoptosis. Microdeletions in this gene are associated with the contiguous ABCD1/DXS1375E deletion syndrome.
Alias Symbols: 6C6-AG, BAP31, CDM, DXS1357E
Protein Interaction Partner: PTPLB,ACTG1,APP,BCAP29,BCAP31,BCL2,BCL2L1,CANX,CASP1,CASP3,CASP8,HLA-A,MSN,MYH10,PLP2,PTPLB,VAMP1,VAMP3,ACTG1,BCAP29,BCAP31,BCL2,BCL2L1,CASP1,CASP8,MYH10,VAMP2,VAMP3